Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1654 1656 1678
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17929124 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18267024 | METHODS AND MATERIALS FOR TREATING PROSTATE CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17725407 | METHODS AND COMPOSITIONS FOR THE POSITIVE SELECTION OF PROTEIN DESTABILIZERS | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 17997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18507493 | METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION | Non-Final OA | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy